Loggia Nicoletta
SEC insider (Form 3/4/5 filer). CIK 0001979825. Director at Candel Therapeutics, Inc. (CADL). 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in NEEDHAM, MA.
Companies Loggia Nicoletta has filed insider reports for
- Candel Therapeutics, Inc. (CADL): Director
Loggia Nicoletta
CIK: 0001979825
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Candel Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 30, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
380 shares at avg. $8.68- - Jun 30, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
381 shares at avg. $8.64- - Jun 23, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
32K shares- - Mar 31, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
779 shares at avg. $4.11- - Jun 25, 2025CADL
Candel Therapeutics, Inc.
AwardDirect2.1K shares at avg. $4.67$10K - Jun 17, 2025CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
14.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 380 | $8.68 | - | Direct |
| Jun 30, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 381 | $8.64 | - | Direct |
| Jun 23, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 32,000 | - | - | Direct |
| Mar 31, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 779 | $4.11 | - | Direct |
| Jun 25, 2025 | CADL Candel Therapeutics, Inc. | Award | 2,141 | $4.67 | $9,998 | Direct |
| Jun 17, 2025 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 14,240 | - | - | Direct |
1-6 of 6 transactions